Plus   Neg

Cerulean Pharma Inc. (CERU) Is Sinking After Daré Bioscience Agreement

Cerulean Pharma Inc. (CERU) announced Monday morning that it has entered into a definitive stock purchase agreement with privately-held Daré Bioscience through which equityholders of Daré Bioscience will become the majority owners of Cerulean.

Cerulean Pharma has gapped open sharply lower this morning and is now down 2.09 at $1.23 on above average volume. The stock has dropped to a 3-week low.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT